Join the Bacterial Infection group to help and get support from people like you.
Bacterial Infection News (Page 6)
Related terms: Infection, Bacterial
Disease Threat to People From Livestock
FRIDAY, July 7, 2023 – American industry engages in some of the same high-risk practices as other countries in keeping and selling commercial animals that have the potential for triggering outbreaks...
U.S. Livestock, Pet Industries Pose Disease Threat to People
FRIDAY, July 7, 2023 – American industry engages in some of the same high-risk practices as other countries in keeping and selling commercial animals that have the potential for triggering outbreaks...
Chemotherapy-Induced Pseudocellulitis Described in Case Reports
WEDNESDAY, July 5, 2023 – Chemotherapy-induced adverse cutaneous drug reactions that mimic cellulitis, including those termed pseudocellulitis, do not meet criteria for other diagnoses, according to...
FDA Medwatch Alert: IntegraDose Compounding Services, LLC Issues Voluntary Nationwide Recall of Cefazolin Injection Products Due to a Lack of Sterility Assurance
September 21, 2021 – Minneapolis, Minnesota, IntegraDose Compounding Services is voluntarily recalling nine lots, listed in the table below, of cefazolin 2 gram in 20 mL syringe for injection and...
FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections
November 14, 2019 – The U.S. Food and Drug Administration today approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary...
FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
KENILWORTH, N.J.--(BUSINESS WIRE)-- July 17, 2019 Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Nuzyra (omadacycline) for Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections
BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) – Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the U.S. Food and Drug Administration (FDA) has approved Nuzyra (omadacycline) for the...
FDA Medwatch Alert: Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall - Presence of Visible Particulate Matter
ISSUE: AuroMedics Pharma LLC is voluntarily recalling one lot of Levofloxacin in 5% Dextrose Injection 250mg/50mL in a Single-Use flexible container NDC 55150-243-46, Lot CLF160003, Expiry date May...
FDA Medwatch Alert: Vancomycin Hydrochloride for Injection, USP, 750 mg/vial by Hospira: Recall - Presence of Particulate Matter
ISSUE: Hospira is voluntarily recalling one lot of Vancomycin Hydrochloride for Injection, USP, 750 mg/vial (NDC 0409-6531-02) lot 632153A, to the hospital/retailer level. The recall was due to a...
FDA Medwatch Alert: Clindamycin Injection ADD-Vantage Vials by Alvogen: Recall - Lack of Sterility Assurance
ISSUE: Alvogen is voluntarily recalling seven lots of Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level due to microbial growth detected during a routine simulation of the...
FDA Medwatch Alert: Oxacillin for Injection, USP, 10g by Sagent: Recall - Iron Oxide Particulate Matter
ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of one lot of Oxacillin for Injection, USP, 10 g (NDC 25021-163-99) Lot OXT512 (Exp. Date March 2017) manufactured by...
FDA Medwatch Alert: Amikacin Sulfate Injection USP 500 mg/2 mL (250 mg/mL) and 1 Gram/4 mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter
ISSUE: Teva Pharmaceuticals announced a voluntary recall of seven lots of Amikacin Sulfate Injection USP, 500 mg/2mL (250 mg/mL) and 1 gram/4mL (250 mg/mL) vials due to the potential for the presence...
FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects
ISSUE: FDA approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). Includes the following currently available fluoroquinolones:...
FDA Approves New Formulation of Minocin (minocycline) for Injection
PARSIPPANY, N.J.--(BUSINESS WIRE)--Apr. 20, 2015-- The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug...
FDA Medwatch Alert: Vancomycin Hydrochloride for Injection USP, Equivalent to 1 Gram Vancomycin (Sterile Powder) by Hospira, Inc.: Recall - Uncontrolled Storage During Transit
ISSUE: Hospira, Inc. issued a voluntary nationwide user-level recall of one lot of Vancomycin Hydrochloride for Injection, USP, Equivalent to 1 g Vancomycin (Sterile Powder), NDC 0409-6533-01, Lot...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Bacterial Skin Infection, Skin and Structure Infection, Bacterial Vaginitis, Lyme Disease, Methicillin-Resistant Staphylococcus Aureus Infection, Infections
Related drug support groups
amoxicillin, metronidazole, doxycycline, cephalexin, clindamycin, azithromycin, Bactrim, Cipro, Zithromax, view more... ciprofloxacin, Keflex, Flagyl, Levaquin, Augmentin, levofloxacin, sulfamethoxazole, sulfamethoxazole / trimethoprim, vancomycin, amoxicillin / clavulanate, cefdinir, Bactrim DS, tetracycline, Rocephin, garlic